IAKENTRO Fertility Center
Thessaloniki, 542 50, Greece
NCT Number: NCT04408547
Analysis our Embryo transfer data, prospectively collected during the last 6 years (2014- 2019), performed by the same operator YP, who has been doing embryo transfers since 1984. All factors that might impact the embryo transfer will be analyzed. We want to see which factors that influence the success rate are not related to the subjectivity of the operator and could be adjusted through different approaches.
Looking for future studies?
Notify MeMost patients undergoing IVF or ICSI reach a blastocyst embryo transfer but less achieve pregnancy and live birth. Many reasons have been proposed to explain these results. Among them, the factor Embryo Transfer Procedure gained less of the attention since few papers have been published and most of them had a lot of biases. In order to eliminate possible biases, we wanted to analyze our Embryo transfer data, prospectively collected during the last 6 years (2014- 2019), performed by the same operator YP, who has been doing embryo transfers since 1984. All factors that might impact the embryo transfer will be analyzed. We want to see which factors that influence the success rate are not related to the subjectivity of the operator and could be adjusted through different approaches.
Primary outcomes: bhCG positive rate, pregnancy rate, ongoing pregnancy rate, live birth rate.
Secondary outcomes: Full bladder, uterine ax orientation, Endometrial thickness, type of catheter, straightforward advancement of the preloaded catheter, use of a stiffer hard catheter to pass through the cervix and the orifice, the site of the uterine cavity that the embryo was released, single or double transfer due to blocked embryo in the catheter.
In addition for each embryo transfer variables that may influence the pregnancy rates will be collected: age of the woman, number of oocytes harvested, sperm characteristics, fertilization rate, stage and grade of the embryos the day of transfer
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
undergoing embryo transfer
Time frame: Number of patients bhCG positive up to12 days after embryo transfer
Number of patients bhCG positive up to12 days after embryo transfer
Time frame: Number of patients with on going clinical pregnancy up to 12 weeks after embryo transfer
Number of patients with on going clinical pregnancy up to12 weeks after embryo transfer
Time frame: Number oflive birth up to 9 months after embryo transfer
Number oflive birth up to9 months after embryo transfer
Time frame: At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Percentage of fullness of the bladder during embryo transfer
Time frame: prior to embryo transfer
Endometrial thickness prior to embryo transfer
Time frame: At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Uterine axe orientation during embryo transfer
Time frame: At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Type of embryo transfer catheter used in the procedure
Time frame: At the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Distance from the fundus of the embryo release
Time frame: Number of patients who underwent embryo transfer and the embryo was retained in the catheter at the time of embryo transfer and the impact of pregnancy test result 12 days after the mebryo transfer
Embryo retained in the catheter
Iakentro Fertility Centre
Other
Acronym: IAFACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05109676
IVF
Toulouse, France
View Trial DetailsNCT05951400
IVF, PCO
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT05954962
IVF
Elche, Alicante, Spain
View Trial DetailsNCT04806919
Abortion, Spontaneous, Death
Ghent, Belgium
View Trial Details